Dashboard
Manage Tickers

INSM INSMED Inc

Nasdaq insmed.com


$ 189.73 $ -4.62 (-2.38 %)    

Friday, 31-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 189.6
$ 194.57
$ 182.26 x 1
$ 197.80 x 8
$ 187.02 - $ 197.08
$ 60.40 - $ 197.08
3,156,070
na
40.44B
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 10-27-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-17-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 04-30-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-22-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-insmed-raises-price-target-to-217
Wells Fargo Maintains Overweight on Insmed...
10/31/2025 21:03:52

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $171 to $217.

heres-how-much-1000-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 1...
10/31/2025 20:00:49

goldman-sachs-maintains-buy-on-insmed-raises-price-target-to-225
Goldman Sachs Maintains Buy on Insmed, Rai...
10/31/2025 18:03:27

Goldman Sachs analyst Andrea Tan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $196 to $225.

ubs-maintains-buy-on-insmed-raises-price-target-to-223
UBS Maintains Buy on Insmed, Raises Price ...
10/31/2025 15:50:01

UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $194 to $223.

rbc-capital-maintains-outperform-on-insmed-raises-price-target-to-215
RBC Capital Maintains Outperform on Insmed...
10/31/2025 15:00:01

RBC Capital analyst Leonid Timashev maintains Insmed (NASDAQ:INSM) with a Outperform and raises the price target from $139 t...

meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday
Meta Tumbles 10%, Google Marks Historic Ra...
10/30/2025 17:40:46

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

cardinal-health-posts-upbeat-q1-results-joins-guardant-health-glaukos-ch-robinson-and-other-big-stocks-moving-higher-on-thursday
Cardinal Health Posts Upbeat Q1 Results, J...
10/30/2025 14:19:43

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

insmed-raises-fy2025-global-arikayce-sales-guidance-from-405m-425m-to-420m-430m
Insmed Raises FY2025 Global ARIKAYCE Sales...
10/30/2025 11:06:56

Balance Sheet, Financial Guidance, and Planned InvestmentsAs of September 30, 2025, Insmed had cash, cash equivalents, and mark...

insmed-q3-eps-175-misses-138-estimate-sales-142342m-beat-115604m-estimate
Insmed Q3 EPS $(1.75) Misses $(1.38) Estim...
10/30/2025 11:03:44

Insmed (NASDAQ:INSM) reported quarterly losses of $(1.75) per share which missed the analyst consensus estimate of $(1.38) by 2...

a-preview-of-insmeds-earnings
A Preview Of Insmed's Earnings
10/29/2025 18:01:52

b-of-a-securities-maintains-buy-on-insmed-raises-price-target-to-187
B of A Securities Maintains Buy on Insmed,...
10/27/2025 17:36:42

B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $142 to ...

heres-how-much-1000-invested-in-insmed-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 5...
10/23/2025 16:00:35

insmed-says-chmp-recommends-eu-approval-of-brinsupri-brensocatib-for-non-cystic-fibrosis-bronchiectasis-in-patients-12-first-in-class-dpp1-inhibitor-and-first-eu-therapy-for-ncfb
Insmed Says CHMP Recommends EU Approval Of...
10/17/2025 11:10:53

insmed-to-present-six-abstracts-from-phase-3-aspen-study-of-brinsupri-at-chest-2025
Insmed To Present Six Abstracts From Phase...
10/16/2025 11:04:17

—Data on Structural Lung Changes from a High-Resolution CT Substudy to be Presented as Late-Breaker——Additional Analyses Will H...

this-is-what-whales-are-betting-on-insmed
This Is What Whales Are Betting On Insmed
10/15/2025 19:02:07

ubs-maintains-buy-on-insmed-raises-price-target-to-194
UBS Maintains Buy on Insmed, Raises Price ...
10/14/2025 16:02:17

UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $140 to $194.

heres-how-much-1000-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 1...
10/07/2025 15:30:35

goldman-sachs-maintains-buy-on-insmed-raises-price-target-to-196
Goldman Sachs Maintains Buy on Insmed, Rai...
10/03/2025 16:59:31

Goldman Sachs analyst Andrea Tan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $121 to $196.

analyst-expectations-for-insmeds-future
Analyst Expectations For Insmed's Future
10/02/2025 18:00:52

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION